Axis 2
Studiedness
- Evidence amount
- 1.00
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 18
- Records after title/year deduplication
- 18
entity · release 2026-09-20
Lactiplantibacillus plantarum LP299V
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Printed CFU per serving
- 20,000,000,000 – 30,000,000,000; median 20,000,000,000. Measured on the 4 of 5 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
- Cost per day
- $1.17 – $1.17; median $1.17. Measured on the 1 of 5 published products carrying it with an observed price and a computable days-of-supply.
- Forms
- Capsule: 5 · counted across the 5 of 5 published products whose label states a form
- Brands carrying it
- american-health (1) · hyperbiotics (1) · nature-s-bounty (1) · solgar (2)
- Published product pages
- 5
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| American Health Enzyme Probiotic Complex+ | 20,000,000,000 | not printed | not observed | Capsule | 100.00 |
| Solgar Probi 20 | not printed | not printed | not observed | Capsule | 100.00 |
| Solgar Probi 20 Billion | 20,000,000,000 | not printed | not observed | Capsule | 100.00 |
| Nature's Bounty Probiotic GX | 20,000,000,000 | not printed | not observed | Capsule | 100.00 |
| Hyperbiotics PRO-IBS Support+ | 30,000,000,000 | not printed | $1.17 | Capsule | 93.25 |
Containing labels8
Evidence amount1.00
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
18 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2026 · Effects of race distance and probiotics intervention on kidney, muscle, and gut injury and inflammation biomarker responses during running.
- 2025 · Probiotic Supplementation Enhances the Effects of a Nutritional Intervention on Quality of Life in Women with Hashimoto's Thyroiditis-A Double-Blind Randomised Study.
- 2025 · Probiotic Lactobacillus plantarum 299v supplementation in patients with major depression in a double-blind, randomized, placebo-controlled trial: A metabolomics study.
- 2023 · Feasibility Study of Lactobacillus Plantarum 299v Probiotic Supplementation in an Urban Academic Facility among Diverse Pregnant Individuals.
- 2021 · The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial.
- 2021 · Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial.
- 2020 · Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial.
- 2020 · The Effect of Lactobacillus plantarum 299v on Iron Status and Physical Performance in Female Iron-Deficient Athletes: A Randomized Controlled Trial.
- 2019 · Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency.
- 2019 · Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study.
ClinicalTrials.gov
4 interventional studies. ClinicalTrials.gov query
This species has 64 tracked designations; this one appears on 8 labels (median 3.5).
Other printed names
- Lactiplantibacillus plantarum Lp-299v
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 8 of 8 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Solgar | Probi 20 Billion | 45194 | 100.00 | true | 20,000,000,000 CFU | through expiry | 1 |
| Nature's Bounty | Probiotic GX | 242572 | 100.00 | true | 20,000,000,000 CFU | through expiry | 1 |
| Solgar | Probi 20 | 263873 | 100.00 | true | not printed for this organism | through expiry | 1 |
| American Health | Enzyme Probiotic Complex+ | 317675 | 100.00 | true | 20,000,000,000 CFU | through expiry | 2 |
| American Health | Enzyme Probiotic Complex+ | 317676 | 100.00 | true | 20,000,000,000 CFU | through expiry | 2 |
| Hyperbiotics | PRO-IBS Support+ | 328454 | 93.25 | true | 30,000,000,000 CFU | at manufacture | 1 |
| Probiata | Probiata | 42453 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Probiata | Probiata | 46162 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Lactiplantibacillus plantarum LP299V. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/lactiplantibacillus-plantarum-lp299v/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Lactiplantibacillus plantarum LP299V appears on 8 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 5 brands; tied with 12 designations by distinct label count.
8 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324376 of 8 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Lactiplantibacillus plantarum LP299V (75.0%); 2 light records have quantities unavailable.
6 / 8 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f73243718 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 18 records (retracted records excluded; 0 retracted records match the query separately).
18 / 18 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324374 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
4 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371 of 7 SKUs containing Lactiplantibacillus plantarum LP299V have a numeric price observation (14.3%) in the release accompanying the NIH DSLD snapshot Sep 2026.
1 / 7 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437